Intellia Therapeutics (NTLA) EPS (Basic) (2015 - 2026)
Intellia Therapeutics' (NTLA) quarterly EPS (Basic) came in at -$1.62 in Q1 2026, up 34.16% year-on-year from -$1.21 in Q1 2025, and down 90.46% on a QoQ basis from -$0.85 in Q4 2025.
Intellia Therapeutics (NTLA) EPS (Basic) (2015 - 2026) Analysis & Trends
Intellia Therapeutics (NTLA) has 12 years of EPS (Basic) data on file, last reported at -$1.62 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 34.16% year-over-year to -$1.62 in Q1 2026; TTM through Mar 2026 was -$5.28, a 18.23% increase from a year earlier, with the FY2025 full-year figure at -$12.24, up 4.71% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.62, down from -$0.85 in the prior quarter.
- Over the last five years, EPS (Basic) for NTLA reached as high as -$0.85 in Q4 2025 and fell as low as -$4.66 in Q1 2022.
- Historically, EPS (Basic) has averaged -$1.93 across 5 years, with a median of -$1.78 in 2023.
- Across the five-year window, EPS (Basic) jumped 99.88% in 2022 and sank 82.36% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$1.41 in 2022, then slumped by 30.48% to -$1.84 in 2023, then soared by 30.46% to -$1.28 in 2024, then jumped by 33.46% to -$0.85 in 2025, then plunged by 90.46% to -$1.62 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$1.62 in Q1 2026, -$0.85 in Q4 2025, and -$2.02 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Intellia Therapeutics | 1.27 Bn | 1.27 Bn | - | -1.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.62 |
| Dec 31, 2025 | -0.85 |
| Sep 30, 2025 | -2.02 |
| Jun 30, 2025 | -1.14 |
| Mar 31, 2025 | -2.46 |
| Dec 31, 2024 | -1.28 |
| Sep 30, 2024 | -1.42 |
| Jun 30, 2024 | -1.47 |
| Mar 31, 2024 | -1.35 |
| Dec 31, 2023 | -1.84 |
| Sep 30, 2023 | -1.78 |
| Jun 30, 2023 | -2.14 |
| Mar 31, 2023 | -1.82 |
| Dec 31, 2022 | -1.41 |
| Sep 30, 2022 | -2.90 |
| Jun 30, 2022 | -2.68 |
| Mar 31, 2022 | -4.66 |
| Dec 31, 2021 | -1,157.18 |
| Sep 30, 2021 | -9.14 |
| Jun 30, 2021 | -15.31 |